Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Neely

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|January 14, 2018
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic DrugsPieter J Glerum, Yang Yu, Walter M Yamada, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 4, 2025
Analyzing Pharmacodynamic Count Data That Rapidly Decrease to ZeroWalter M Yamada, Alan Schumitzky, Alona Kryshchenko, et al.
Clinical Pharmacology and Therapeutics|June 11, 2026
Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug DosingMarc H Scheetz, Thomas P Lodise, Nathaniel J Rhodes, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2021
Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatricsSean N Avedissian, Jennifer Le, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2013
Are vancomycin trough concentrations adequate for optimal dosing?Michael N Neely, Gilmer Youn, Brenda Jones, et al.
Pharmacotherapy|April 30, 2026
Bayesian Dosing Simulator (BDS): A Pharmacokinetic Modeling Tool for Optimized Antibiotic TherapyAdrian Valadez, Marc H Scheetz, Michael N Neely, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform NeurofibromasZoltán Köllő, Janka Kovács, Michael N Neely, et al.
Pharmacology Research & Perspectives|September 3, 2021
A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapyGellért Balázs Karvaly, István Karádi, István Vincze, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|January 14, 2018
Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic DrugsPieter J Glerum, Yang Yu, Walter M Yamada, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 4, 2025
Analyzing Pharmacodynamic Count Data That Rapidly Decrease to ZeroWalter M Yamada, Alan Schumitzky, Alona Kryshchenko, et al.
Clinical Pharmacology and Therapeutics|June 11, 2026
Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug DosingMarc H Scheetz, Thomas P Lodise, Nathaniel J Rhodes, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2021
Comment on: AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatricsSean N Avedissian, Jennifer Le, Michael N Neely, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2013
Are vancomycin trough concentrations adequate for optimal dosing?Michael N Neely, Gilmer Youn, Brenda Jones, et al.
Pharmacotherapy|April 30, 2026
Bayesian Dosing Simulator (BDS): A Pharmacokinetic Modeling Tool for Optimized Antibiotic TherapyAdrian Valadez, Marc H Scheetz, Michael N Neely, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2025
A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform NeurofibromasZoltán Köllő, Janka Kovács, Michael N Neely, et al.
Pharmacology Research & Perspectives|September 3, 2021
A pharmacokinetics-based approach to the monitoring of patient adherence to atorvastatin therapyGellért Balázs Karvaly, István Karádi, István Vincze, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 15, 2013
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantationAnders Åsberg, Karsten Midtvedt, Mike van Guilder, et al.
Pageof 9